Eliem Therapeutics Market Value

ELYMDelisted Stock  USD 3.00  0.08  2.60%   
Eliem Therapeutics' market value is the price at which a share of Eliem Therapeutics trades on a public exchange. It measures the collective expectations of Eliem Therapeutics investors about its performance. Eliem Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Eliem Therapeutics was actively traded. Please check the stock traded under the symbol CLYM.
With this module, you can estimate the performance of a buy and hold strategy of Eliem Therapeutics and determine expected loss or profit from investing in Eliem Therapeutics over a given investment horizon. Check out Eliem Therapeutics Correlation, Eliem Therapeutics Volatility and Eliem Therapeutics Alpha and Beta module to complement your research on Eliem Therapeutics.
Symbol

Please note, there is a significant difference between Eliem Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eliem Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eliem Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eliem Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eliem Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eliem Therapeutics.
0.00
10/26/2024
No Change 0.00  0.0 
In 31 days
11/25/2024
0.00
If you would invest  0.00  in Eliem Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Eliem Therapeutics or generate 0.0% return on investment in Eliem Therapeutics over 30 days. Eliem Therapeutics is related to or competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, Anebulo Pharmaceuticals, Rezolute, and HCW Biologics. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitabil... More

Eliem Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eliem Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eliem Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Eliem Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Eliem Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eliem Therapeutics' standard deviation. In reality, there are many statistical measures that can use Eliem Therapeutics historical prices to predict the future Eliem Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eliem Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.163.248.70
Details
Intrinsic
Valuation
LowRealHigh
0.142.858.31
Details
Naive
Forecast
LowNextHigh
0.073.288.75
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.653.364.07
Details

Eliem Therapeutics Backtested Returns

Eliem Therapeutics secures Sharpe Ratio (or Efficiency) of -0.18, which denotes the company had a -0.18% return per unit of risk over the last 3 months. Eliem Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eliem Therapeutics' Variance of 29.04, standard deviation of 5.39, and Mean Deviation of 3.92 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.17, which means not very significant fluctuations relative to the market. As returns on the market increase, Eliem Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Eliem Therapeutics is expected to be smaller as well. At this point, Eliem Therapeutics has a negative expected return of -0.96%. Please make sure to confirm Eliem Therapeutics' maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Eliem Therapeutics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.82  

Very good predictability

Eliem Therapeutics has very good predictability. Overlapping area represents the amount of predictability between Eliem Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eliem Therapeutics price movement. The serial correlation of 0.82 indicates that around 82.0% of current Eliem Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.82
Spearman Rank Test0.81
Residual Average0.0
Price Variance0.13

Eliem Therapeutics lagged returns against current returns

Autocorrelation, which is Eliem Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eliem Therapeutics' stock expected returns. We can calculate the autocorrelation of Eliem Therapeutics returns to help us make a trade decision. For example, suppose you find that Eliem Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Eliem Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eliem Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eliem Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eliem Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

Eliem Therapeutics Lagged Returns

When evaluating Eliem Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eliem Therapeutics stock have on its future price. Eliem Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eliem Therapeutics autocorrelation shows the relationship between Eliem Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Eliem Therapeutics.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Eliem Therapeutics Correlation, Eliem Therapeutics Volatility and Eliem Therapeutics Alpha and Beta module to complement your research on Eliem Therapeutics.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Eliem Stock

If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon